Clinical Trial Update: Developing Hyperpolarized Gas MRI Signatures to Detect and Manage Acute Cellular Rejection [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update investigating hyperpolarized gas MRI signatures to detect and manage acute cellular rejection in lung transplant recipients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Transplant Rejection

Snippet

Sponsor: University of Virginia | Conditions: Lung Transplant Rejection | Phase 2 | Status: RECRUITING